Yocca Frank (CIK 0001733272)

Latest company ownership

BTAI - BioXcel Therapeutics, Inc.
Role: Chief Scientific Officer
Shares held
35
Last filed at
Sep 16, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 14, 2024 Dec 17, 2024 BioXcel Therapeutics, Inc. Chief Scientific Officer Sell 50.0 -430 -1.46% ✓ $151.8
Sep 17, 2024 Oct 3, 2024 BioXcel Therapeutics, Inc. Chief Scientific Officer Sell 90.0 +14,075 99.10% ✓ $3.9K
Sep 14, 2024 Sep 17, 2024 BioXcel Therapeutics, Inc. Chief Scientific Officer Sell 46.3 -355 -2.44% ✓ $244.7
Jun 14, 2024 Jun 18, 2024 BioXcel Therapeutics, Inc. Chief Scientific Officer Sell 46.3 -372 -2.69% ✓ $476.2
Mar 14, 2024 Apr 8, 2024 BioXcel Therapeutics, Inc. Chief Scientific Officer Sell 33.8 -1,067 -7.72% ✓ $2.8K
Mar 14, 2023 Mar 16, 2023 BioXcel Therapeutics, Inc. Chief Scientific Officer Sell 32.5 -985 -9.40% ✓ $19.4K
Jan 20, 2023 Jan 24, 2023 BioXcel Therapeutics, Inc. Chief Scientific Officer Sell 5.0 -50,000 -85.62% ✓ $1.5M
Mar 15, 2021 Mar 17, 2021 BioXcel Therapeutics, Inc. Chief Scientific Officer Sell 12.5 -15,000 -20.44% ✓ $727.6K
Feb 16, 2021 Feb 18, 2021 BioXcel Therapeutics, Inc. Chief Scientific Officer Sell 17.5 -15,000 -16.97% ✓ $865.2K
Jan 25, 2021 Jan 27, 2021 BioXcel Therapeutics, Inc. Chief Scientific Officer Sell 22.5 -15,000 -14.51% ✓ $725.8K
Aug 13, 2019 Aug 14, 2019 BioXcel Therapeutics, Inc. Chief Scientific Officer Buy 95.0 +6,547 353.89% ✗ $56.8K
Dec 3, 2018 Dec 6, 2018 BioXcel Therapeutics, Inc. Chief Scientific Officer Buy 90.0 +900 94.74% ✗ $4.7K
Nov 30, 2018 Nov 30, 2018 BioXcel Therapeutics, Inc. Chief Scientific Officer Buy 90.0 +450 90.00% ✗ $2.3K
Nov 29, 2018 Nov 30, 2018 BioXcel Therapeutics, Inc. Chief Scientific Officer Buy 90.0 +500 100.00% ✗ $2.5K